CFP and Cirrhosis: Because properdin and Factor H are primarily produced by different cell types (properdin by leukocytes, Factor H by hepatocytes), it remains to be determined if preferential dysfunction of leukocytes (such as in chemotherapy) or hepatocytes (such as in cirrhosis) affects the balance between properdin and Factor H in regulating the alternative pathway and if there are associated consequences in particular disease models.